Clinical effectiveness of tigecycline in combination therapy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective multi-centre observational study

Abstract Background Tigecycline has in vitro bacteriostatic activity against a broad spectrum of bacteria, including carbapenem-resistant Gram-negative bacteria (CR-GNB). However, the role of tigecycline in treatment of nosocomial pneumonia caused by CR-GNB remains controversial and clinical evidenc...

Descripció completa

Dades bibliogràfiques

Autors principals:	Kuang-Yao Yang, Chung-Kan Peng, Chau-Chyun Sheu, Yu-Chao Lin, Ming-Cheng Chan, Sheng-Huei Wang, Chia-Min Chen, Chih-Yu Chen, Zhe-Rong Zheng, Jia-Yih Feng, the T-CARE (Taiwan Critical Care and Infection) Group
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2023-01-01
Col·lecció:	Journal of Intensive Care
Matèries:	Nosocomial pneumonia Tigecycline Carbapenem-resistant Gram-negative bacteria Clinical failure Mortality
Accés en línia:	https://doi.org/10.1186/s40560-022-00647-y
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!